| Followers | 17 |
| Posts | 919 |
| Boards Moderated | 0 |
| Alias Born | 04/28/2018 |
Friday, May 05, 2023 11:12:47 PM
I normally don't reply to posts, but I'll make an exception since it's directed at me. Mate, I'm agnostic when it comes to the science, I'm not even trying to profit from my trades. Cancer has touched my life as it has I'm sure everyone who is interested this space don't you know. I'm investing in companies that I believe can and will make a difference. In the end it all goes to charity. I like the action, and I like what I see as far as what $NVCR is doing. In the end it's all going to charity. GLTA
Recent NVCR News
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/20/2026 08:06:05 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/20/2026 08:05:43 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/09/2026 09:04:13 PM
- Novocure to Report First Quarter 2026 Financial Results • Business Wire • 04/01/2026 11:00:00 AM
- Novocure shares gain on encouraging pancreatic cancer trial results • IH Market News • 03/26/2026 02:24:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/26/2026 11:00:57 AM
- Novocure Announces Positive Topline Results from Phase 2 PANOVA-4 Clinical Trial of Tumor Treating Fields (TTFields) Therapy for Metastatic Pancreatic Cancer • Business Wire • 03/26/2026 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2026 09:33:25 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2026 09:32:48 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2026 09:32:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2026 09:31:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2026 09:31:35 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2026 09:31:19 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2026 09:31:04 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/05/2026 09:06:50 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/04/2026 10:54:58 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/04/2026 10:53:45 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/04/2026 10:42:44 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/04/2026 10:13:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/03/2026 09:11:29 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/02/2026 10:40:37 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/02/2026 09:14:39 PM
- Novocure Announces Optune Lua® Receives Reimbursement Approval in Japan for the Treatment of Non-Small Cell Lung Cancer • Business Wire • 03/02/2026 12:00:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/27/2026 10:13:31 PM
- Novocure to Participate in 2026 Leerink Global Healthcare Conference • Business Wire • 02/27/2026 09:30:00 PM
